For companies eying international markets, a major concern must be the complexity and cost of securing effective patent protection outside of the U.S. A savvy intellectual property strategy, informed by the pros and cons of patenting overseas, is essential to deciding when, where, and why to seek ex-U.S. coverage.
On April 9th, Foley Senior Counsel Brian McCaslin will discuss how small business can address the uncertainties of building an international patent portfolio at an MIT Enterprise Forum’s Get SMART Program. The presentation will illuminate general principles of patenting abroad and specific considerations relating to key countries in Asia and Europe.
Related Insights
20 December 2024
Health Care Law Today
GLP-1 Drugs: FDA “Re-Confirms” Decision Removing Tirzepatide from the Drug Shortage List
On December 19, 2024, the U.S. Food and Drug Administration (FDA) issued a Declaratory Order reevaluating and re-confirming that the tirzepatide drug shortage has been resolved. This order revoked and replaced FDA’s October 2, 2024, decision on tirzepatide.
20 December 2024
Manufacturing Industry Advisor
Christmas Came Early: Justice Delivered in Supplier Dispute Over Unjust Enrichment
The AirBoss saga continues… This holiday season, AirBoss Flexible Products Co. received a monumental legal victory, righting a costly wrong in MSSC, Inc. v. AirBoss.
19 December 2024
Health Care Law Today
HIPAA Reproductive Health Care Amendments: Compliance in an Uncertain Enforcement Landscape
The amendments to the HIPAA Privacy Rule designed to protect reproductive health care information are under legal challenge as the compliance date quickly approaches.